Imetelstat
Geron Corporation
['imerge trial', 'nct02598661']
the pivotal phase iii imerge trial (nct02598661) results with an october 2022 data cut-off were presented at the annual meeting; the top-line results for the same were released in january 2023. get a detailed overview of the result, at: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry